Great posts Jake and Respy. Anxious to try Nader'
Post# of 148158
Don't know if I can be forgiven for stating the Ultraobvious, but to me the most telling argument pointing toward our new drugmaker being someone other than --someone vastly more interesting than -- AGC is the fact that they were not named. If it were AGC, there's no reason not to mention that it's them. So one of the NDAs must cover this deal. And why would we need not to mention the name of the new drugmaker?
Just as Jake and Respy and MLab have said: it's our Mysterious Stranger. Respy says GSK. I say Merck. Potatoes potatoes. It's BP.